Use of neurally adjusted ventilatory assist (NAVA) in a patient with severe SARS-CoV-2 pneumonia: A case report.

Journal: Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR
Published Date: Jul 22, 2021

Abstract

INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia may necessitate intubation and prolonged mechanical ventilation. Early in the course of mechanical ventilation neuromuscular blocking agents may be used to allow synchronous lung protective ventilation. However, patients with SARS-CoV-2 pneumonia tend to have an intense respiratory drive resulting in patient-ventilator asynchrony when neuromuscular blocking agents are discontinued.

Authors

  • Jeffrey M Haynes
    Respiratory Therapy Department, St. Joseph Hospital, Nashua, NH, USA.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals